{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:20:24Z","timestamp":1790864424229,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nbd.2014.08.011","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T18:01:48Z","timestamp":1408125708000},"page":"280-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":251,"special_numbering":"C","title":["Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease"],"prefix":"10.1016","volume":"71","author":[{"given":"Augusta","family":"Pisanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Wardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Simbula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saturnino","family":"Spiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.08.011_bb0275","doi-asserted-by":"crossref","first-page":"e61700","DOI":"10.1371\/journal.pone.0061700","article-title":"Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model","volume":"8","author":"Alvarez-Fischer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.08.011_bb0305","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.nbd.2005.09.001","article-title":"Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits","volume":"21","author":"Andrews","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.011_bb0140","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.neurobiolaging.2006.04.011","article-title":"Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra","volume":"6","author":"Arimoto","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.08.011_bb0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/glia.20015","article-title":"Evidence of active microglia in substantia nigra pars compacta of Parkinsonian monkeys 1year after MPTP exposure","volume":"46","author":"Barcia","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.08.011_bb0255","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease","volume":"2","author":"Barcia","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2014.08.011_bb0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/138161206780574579","article-title":"PPAR-gamma agonists as regulators of microglial activation and brain inflammation","volume":"12","author":"Bernardo","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2014.08.011_bb0180","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1046\/j.1460-9568.2000.00110.x","article-title":"Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions","volume":"12","author":"Bernardo","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0365","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.011_bb0075","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"2","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.08.011_bb0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1389450111314070004","article-title":"PPAR-\u03b3: therapeutic prospects in Parkinson's disease","volume":"14","author":"Carta","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.nbd.2014.08.011_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12640-012-9342-7","article-title":"Modulating microglia activity with PPAR-\u03b3 agonists: a promising therapy for Parkinson's disease?","volume":"23","author":"Carta","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2014.08.011_bb0230","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1460-9568.2005.03944.x","article-title":"Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment","volume":"21","author":"Carta","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuroscience.2011.07.046","article-title":"Rosiglitazone decreases peroxisome proliferator receptor-\u03b3 levels in microglia and inhibits TNF-\u03b1 production: new evidences on neuroprotection in a progressive Parkinson's disease model","volume":"194","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.011_bb0315","first-page":"189","article-title":"Glia, cytokines, and neurotoxicity","volume":"2\u20133","author":"Chao","year":"1995","journal-title":"Neurobiology"},{"key":"10.1016\/j.nbd.2014.08.011_bb0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.55782\/ane-2003-1461","article-title":"Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease","volume":"2","author":"Ciesielska","year":"2003","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.nbd.2014.08.011_bb0395","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists","volume":"20","author":"Combs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the Parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2014.08.011_bb0100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.nbd.2009.11.018","article-title":"Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia\/macrophage activation","volume":"37","author":"De Lella Ezcurra","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.011_bb0165","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.011_bb0235","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1460-9568.2003.03014.x","article-title":"Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease","volume":"18","author":"Depino","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2003.11.010","article-title":"Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis","volume":"148","author":"Diab","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0335","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.2337\/db08-1475","article-title":"Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice","volume":"58","author":"Fujisaka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2014.08.011_bb0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.011_bb0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.expneurol.2010.08.016","article-title":"Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor \u03b21 is enhanced after co-infusion in rats","volume":"226","author":"Gonzalez-Aparicio","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0310","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00415-006-0414-6","article-title":"Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson's disease","volume":"254","author":"Goris","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/glia.21254","article-title":"Regulation of microglia effector functions by tumor necrosis factor signaling","volume":"2","author":"Harms","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.08.011_bb0010","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","article-title":"Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?","volume":"44","author":"Hirsch","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijdevneu.2005.11.001","article-title":"Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology","volume":"24","author":"Hoozemans","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0250","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0405","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.011_bb0410","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1523\/JNEUROSCI.3024-08.2008","article-title":"Inflammatory response in the hippocampus of pS1M146L\/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic","volume":"28","author":"Jimenez","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0145","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/mt.2008.113","article-title":"Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease","volume":"8","author":"Johnston","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2014.08.011_bb0370","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","author":"Kiaei","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0340","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1124\/mol.105.017160","article-title":"Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma","volume":"68","author":"Kim","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/jnr.490420516","article-title":"Trophic and protective effects of growth\/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons","volume":"42","author":"Krieglstein","year":"1995","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2014.08.011_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fncel.2013.00053","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1: reliable targets for protective therapies in Parkinson's disease?","volume":"7","author":"Leal","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0320","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3","article-title":"Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells","volume":"2","author":"Ledeboer","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.08.011_bb0325","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jlb.60.4.502","article-title":"Regulation of microglial activation by TGF-beta, IL-10, and CSF-1","volume":"4","author":"Lodge","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000320027","article-title":"MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain","volume":"18","author":"Lofrumento","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.nbd.2014.08.011_bb0265","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","article-title":"Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease","volume":"1\u20132","author":"Luchman","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.nbd.2014.08.011_bb0270","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbr.2011.09.033","article-title":"Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease","volume":"226","author":"Luchtman","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2014.08.011_bb0400","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.M414390200","article-title":"Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation","volume":"280","author":"Luna-Medina","year":"2005","journal-title":"Biol. Chem."},{"key":"10.1016\/j.nbd.2014.08.011_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2006.07.007","article-title":"The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions","volume":"180","author":"Lund","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0375","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1471-4159.2006.03758.x","article-title":"Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone","volume":"97","author":"Luo","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.011_bb0285","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","article-title":"Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease","volume":"110","author":"Marinova-Mutafchieva","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.011_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-5-45","article-title":"TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease","volume":"5","author":"McCoy","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2014.08.011_bb0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410240415","article-title":"Rate of cell death in parkinsonism indicates active neuropathological process","volume":"24","author":"McGeer","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.08.011_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(95)11686-Q","article-title":"Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease","volume":"193","author":"Mogi","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.08.011_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","article-title":"Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile Parkinsonism and Parkinson's disease","volume":"211","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.08.011_bb0415","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1074\/jbc.M412170200","article-title":"Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus","volume":"280","author":"Nolan","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.08.011_bb0195","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.08.011_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0301-0082(02)00127-2","article-title":"An inflammatory review of Parkinson's disease","volume":"68","author":"Orr","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0350","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","author":"Park","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2014.08.011_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/9780470985571.ch16","article-title":"Anti-inflammatory and antidiabetic roles of PPARgamma","volume":"286","author":"Pascual","year":"2007","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.nbd.2014.08.011_bb0380","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1460-9568.2008.06478.x","article-title":"Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia","volume":"28","author":"Patzer","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1742-2094-8-174","article-title":"Temporal pattern of expression and colocalization of microglia\/macrophage phenotype markers following brain ischemic injury in mice","volume":"8","author":"Perego","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2014.08.011_bb0220","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.011_bb0105","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/brain\/awn101","article-title":"Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease","volume":"131","author":"Pott Godoy","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.08.011_bb0295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1359-6101(97)00018-X","article-title":"TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases","volume":"8","author":"Pratt","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.nbd.2014.08.011_bb0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0404.2008.01103.x","article-title":"Circulating interleukin-10 and interleukin-12 in Parkinson's disease","volume":"5","author":"Rentzos","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2014.08.011_bb0385","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.08.011_bb0065","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","article-title":"Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease","volume":"58","author":"Rojo","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.08.011_bb0300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4419-0322-8_8","article-title":"TGF-beta in dopamine neuron development, maintenance and neuroprotection","volume":"651","author":"Roussa","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/AN20120066","article-title":"Neuroimmunological processes in Parkinson's disease and their relation to \u03b1-synuclein: microglia as the referee between neuronal processes and peripheral immunity","volume":"30","author":"Sanchez-Guajardo","year":"2013","journal-title":"ASN Neuro"},{"key":"10.1016\/j.nbd.2014.08.011_bb0205","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.2337\/dc09-1315","article-title":"Unbalanced M1\/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone","volume":"33","author":"Satoh","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nbd.2014.08.011_bb0330","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1046\/j.1471-4159.1999.721466.x","article-title":"Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia","volume":"4","author":"Sawada","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.011_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-211-45295-0_57","article-title":"Role of cytokines in inflammatory process in Parkinson's disease","volume":"70","author":"Sawada","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2014.08.011_bb0170","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1460-9568.2009.06657.x","article-title":"PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease","volume":"29","author":"Schintu","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.011_bb0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2014.08.011_bb0130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nbd.2006.10.005","article-title":"GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action","volume":"25","author":"Schober","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.011_bb0095","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1096\/fj.05-5106com","article-title":"Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha","volume":"20","author":"Sriram","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2014.08.011_bb0210","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","article-title":"Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms","volume":"28","author":"Straus","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in Parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2014.08.011_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0092-8674(00)81575-5","article-title":"PPARgamma promotes monocyte\/macrophage differentiation and uptake of oxidized LDL","volume":"93","author":"Tontonoz","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.08.011_bb0190","first-page":"1007","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"2011","author":"Varga","year":"1812","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.08.011_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00005-012-0181-2","article-title":"The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain","volume":"60","author":"Varnum","year":"2012","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.nbd.2014.08.011_bb0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuroscience.2010.12.005","article-title":"Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat","volume":"175","author":"Walsh","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.011_bb0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0030","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson's disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.011_bb0355","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-5-4","article-title":"Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K\/Akt","volume":"5","author":"Xing","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2014.08.011_bb0360","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.4049\/jimmunol.178.3.1904","article-title":"Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia","volume":"178","author":"Xu","year":"2007","journal-title":"J. Immunol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T14:01:41Z","timestamp":1717250501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114002423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":83,"alternative-id":["S0969996114002423"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.011","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}